NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

Can B Corp

Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024

$0.01−0.00 (-1.32%)

Close on Oct 19, 2026

Market cap: $981.54K
P/E (TTM): –
Dividend yield: –

Dividends

Can B has not reported a dividend

No dividend per share appears in Can B's annual filings since fiscal 2014.

Where these numbers come from

Parsed from the XBRL in Can B's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on Apr 15, 2022
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NASC.

Revenue growth-57.7% · median 5.1%

Gross margin-33.2% · median 69.2%

Operating margin-1035.9% · median -0.8%

Net margin-1282.8% · median -15.7%

Company	Revenue	Growth
COR	$332.77B	+5.1%
HLF	$5.20B	+5.5%
NUS	$1.38B	-15.4%
COSM	$73.73M	+33.8%
STEK	$2.40M	-38.6%
NASC	$1.03M	-57.7%

Company

Exchange: OTC
Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries
Fiscal year ends: December 31
Employees: 12
Auditor: BF Borgers CPA PC
SEC CIK: 1509957

Advertisement
300 × 250